drugset / Trial / NCT02246855

A Comparison of the Pharmacokinetics, Safety and Tolerance of Two Formulations of a Liquid IVIg in Healthy Volunteers

NCT02246855

Phase 1 Completed Bio Products Laboratory
Treatment

Summary

The main object of the study is to compare the AUC0-84, of a single intravenous infusion of Vigam® Liquid (infused at the licensed rate of up to 3mL/min) with Gammaplex® (infused at up to 3mL/min and up to 6mL/min).

Timeline

Start
2004-08
Primary completion
2004-12
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Immune Globulin Intravenous (Human) Protein / enzyme biologic Intravenous

Indications

No indication recorded.